NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/09/2023
Voltar para busca
Dado oficial do USPTO
MEDPRO SYSTEMS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
MEDPRO SYSTEMS
ST13
US500000097660589Classe
35, 41, 42, 45
Pedido
97660589
Registro
7164034
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
15
Atualização mais recente
12/09/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 41, 42, 45
Data de depósito
03/11/2022
Data de registro
12/09/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/09/2023
Última transação
12/09/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Primeiro uso
01/04/2021
Primeiro uso no comércio
01/04/2021
Código do desenho
4
Tipo de titular
16
Localização do titular
Mt. Arlington, NJ
Examinador
RADEMACHER, APRIL
Unidade examinadora
L80
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
MedPro Systems LLC
Representantes
Christine Amara SHERMAN ATLAS SYLVESTER & STAMELMAN LLP
Classificação técnica
Classes Nice
Classe 35Classe 41Classe 42Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business consulting services for life sciencespharmaceuticalsbiotechnology and medical device companies in the nature of regulatory compliance program development and enhancement and transparency program supportreviewing program status and performing gap analysesdrafting programs plansprogram implementation supportdevelopment and improvement of policiesstandard operating procedures and codes of conduct; business consulting services in the nature of monitoring of pharmaceutical and medical device manufacturer interactions with healthcare professionalshealthcare organizationspatientsother customers; business consulting services in the nature of auditing of pharmaceutical and medical device manufacturer interactions with and payments to healthcare professionalshealthcare organizationspatientsother customers; business consulting services in the nature of business investigation support for internally and externally raised complaints made against a pharmaceutical or medical device manufacturer related to potential violations of their company policy or codeindustry codelaw or regulation; transparency reporting regulatory submission managementassisting others in preparing and filing regulatory submissions in the field of transparency reporting for pharmaceuticalbiotechnology and medical device companies; business consulting servicestracking and monitoring regulatory requirements for others in the field of life sciencespharmaceuticalsbiotechnologymedical devices for regulatory compliance; business consulting servicescompliance program gap analysis for life sciencespharmaceuticalbiotechnologymedical device companies
Classe 41
Consulting services in the nature of conducting trainings for life sciencespharmaceuticalsbiotechnologymedical device companies personnel and partners on pharmaceutical and medical device compliance program requirementsfraud and corruption laws and regulationsindustry codes and best practices; consulting servicesdeveloping and providing trainings for life sciencespharmaceuticalbiotechnologymedical device companies in the field of corporate compliance and transparency programs
Classe 42
Software as a service (SaaS) services featuring software for use to assist in tracking and reporting healthcare practitioner and healthcare organization interactions and complying with internationalfederalstate and local spend and transparency laws and regulations; software as a service (SaaS) services featuring software to assist pharmaceuticalbiotechnology and medical device companies in managingvalidating and enriching healthcare organization and healthcare practitioner data attributes in connection with regulatory compliancesales and marketing efforts
Classe 45
Regulatory compliance consulting in the field of life sciencespharmaceuticalsbiotechnologymedical devices; consulting services to assist life sciencespharmaceuticalbiotechnology and medical device companies in the fields of regulatory compliancecompliance in the areas of aggregate spend disclosure reportingthe Prescription Drug Marketing Actthe Drug Supply Chain Security ActCondition of Participation for Outpatient ServicesStark Law and Ohio Terminal Distributor of Dangerous Drugs requirements; regulatory compliance audits for life sciencespharmaceuticalbiotechnology and medical device companies to assist with regulatory compliance; consulting services in the field of life sciencespharmaceuticalbiotechnology and medical device corporate compliance program and transparency program developmentimplementation and support; online searchable databases and information concerning historicalcurrent and pending lawsregulationsguidance documents governing the life sciences industry; regulatory compliance consulting services in the field of aggregate spend disclosure reporting; regulatory and compliance information for pharmaceuticalbiotechnology and medical device companiesfor entities involved in the drug and device supply chainregarding transparency and aggregate spendmarketingadditional compliance requirements; regulatory compliance consultingreviewingdevelopingtraining on and assisting with the implementation and monitoring of standardspracticesprocedures and policies to support regulatory compliance for companies in the fields of life sciencespharmaceuticalsbiotechnologymedical devices
Publicações
Histórico de despachos e eventos da marca no USPTO.
15 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
12/09/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
27/06/2023
PUBO
PUBLISHED FOR OPPOSITION
27/06/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/06/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/05/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/04/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/04/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/04/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
14/01/2023
GNRT
NON-FINAL ACTION E-MAILED
14/01/2023
CNRT
NON-FINAL ACTION WRITTEN
14/01/2023
DOCK
ASSIGNED TO EXAMINER
24/12/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/11/2022
NWAP
NEW APPLICATION ENTERED
07/11/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MEDPRO SYSTEMS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.